Classification approaches have been developed, adopted, and applied to distinguish disease classes at the molecular level using microarray data. Recently, a novel class of hierarchical probabilistic models based on a kernel-imbedding technique has become one of the best classification tools for microarray data analysis. These models were first developed as kernel-imbedded Gaussian processes (KIGPs) for binary class classification problems using microarray gene expression data, then they were further improved for multiclass classification problems under a unifying Bayesian framework. Specifically, an adaptive algorithm with a cascading structure was designed to find appropriate featuring kernels, to discover potentially significant genes, and to make optimal disease (e.g., tumor/cancer) class predictions with associated Bayesian posterior probabilities. Simulation studies and applications to publish real data showed that KIGPs performed very close to the Bayesian bound and consistently outperformed or performed among the best of a lot of state-of-the-art methods. The most unique advantage of the KIGP approach is its ability to explore both the linear and the nonlinear underlying relationships between the target features of a given disease classification problem and the involved explanatory gene expression data. This line of research has shed light on the broader usability of the KIGP approach for the analysis of other high-throughput omics data and omics data collected in time series fashion, especially when linear model based methods fail to work.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/978-1-61779-400-1_5 | DOI Listing |
Int J Biol Markers
January 2025
Department of Respiratory and Critical Care Medicine, Anyue County People's Hospital, Anyue, China.
Purpose: To detect the prognostic importance of liquid-liquid phase separation (LLPS) in lung adenocarcinoma.
Methods: The gene expression files, copy number variation data, and clinical data were downloaded from The Cancer Genome Atlas cohort. LLPS-related genes were acquired from the DrLLPS website.
Hum Gene Ther
January 2025
Department of Anatomy and Cell Biology, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
Cystic fibrosis (CF) is caused by mutations in the (). While gene therapy holds promise as a cure, the cell-type-specific heterogeneity of expression in the lung presents significant challenges. Current CF ferret models closely replicate the human disease phenotype but have limitations in studying functional complementation through cell-type-specific CFTR restoration.
View Article and Find Full Text PDFOncol Rep
March 2025
Graduate Institute of Nanomedicine and Medical Engineering, College of Medical Engineering, Taipei Medical University, Taipei 11031, Taiwan, R.O.C.
Epidermal growth factor (EGF) binds with its surface receptor to stimulate gene expression and cancer cell proliferation. EGF stimulates cancer cell growth via phosphoinositide 3‑kinase (PI3K) and programmed cell death ligand 1 (PD‑L1) pathways. As an integrin αvβ3 antagonist, heteronemin exhibits potent cytotoxic effects against cancer cells.
View Article and Find Full Text PDFInt J Mol Med
March 2025
Department of Biomedical Sciences, Chung Shan Medical University, Taichung 402306, Taiwan, R.O.C.
Oral squamous cell carcinoma (OSCC) is a type of head and neck cancer (HNC) with a high recurrence rate, which has been reported to be associated with the presence of cancer stem cells (CSCs). Tribbles pseudokinase 3 (TRIB3) is involved in intracellular signaling and the aim of the present study was to investigate the role of TRIB3 in the maintenance of CSCs. Analysis of The Cancer Genome Atlas database samples demonstrated a positive correlation between TRIB3 expression levels and shorter overall survival rates in patients with HNC.
View Article and Find Full Text PDFOncol Rep
February 2025
Department of Medical Laboratory, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong 524000, P.R. China.
Pancreatic cancer is an aggressive tumor, which is often associated with a poor clinical prognosis and resistance to conventional chemotherapy. Therefore, there is a need to identify new therapeutic markers for pancreatic cancer. Although KIN17 is a highly expressed DNA‑ and RNA‑binding protein in a number of types of human cancer, its role in pancreatic cancer development, especially in relation to progression, is currently unknown.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!